A: EEv is an acronym for Extra Evaluation Card. We named our proprietary card EEv because it provides something “extra” that no other evaluation device can – accurate, easy detection of lead and other dangerous metals in the blood of newborn babies and infants.
A: Our decontamination protocol is patented, and the EEvCarrier™ is trademarked and there are patents pending for it – No. 61/803674 and No. 62/340261, filed by Dr. Funk, Dr. McDade, and Dr. Unger under the patronage of Northwestern University. They describe our proprietary heavy-metals-free EEvCarrier™, as well as our patented decontamination protocol.
A: The lab will return screening results to your pediatrician, and their office will contact you.
A: The Center for Disease Control’s Advisory Committee for Childhood Lead Poisoning Prevention provides specific recommendations regarding follow-up and treatment of newborns and infants exposed to lead. Follow-up treatment will differ depending upon the child’s blood lead level, but might include health education, environmental investigation of the child’s home or other locations the child frequents, or chelation therapy, which removes lead from the blood.
A: No. If our screening suggests widespread toxic exposure, then further research will need to be done, but will affect only future newborns whose parents grant consent.
A: Our current turnaround time for screening results is about a week.
A: Feel free to call EnMed MicroAnalytics’ lab services at 888.428.6644, extension 1; if we can’t answer your question or address your concern immediately, then we’ll get back to you by the end of the next business day.